Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant

Heppenstall, Charlotte; Bunce, Susan; Smith, Jamie C
January 2012
Nutrition Journal;2012, Vol. 11, p50
Academic Journal
Background: Weight loss is often difficult to achieve in individuals with type 2 diabetes and anti-obesity drugs are often advocated to support dietary intervention. Despite the extensive use of centrally acting anti-obesity drugs, there is little evidence of how they affect dietary composition. We investigated changes in energy intake and dietary composition of macro- and micronutrients following therapy with the endocannabinoid receptor blocker, rimonabant. Methods: 20 obese patients with type 2 diabetes were studied before and after 6 months dietary intervention with rimonabant. Dietary intervention was supervised by a diabetes dietician. Five-day food diaries were completed at baseline and at 6 months and dietary analysis was performed using computer software (Dietplan 6). Results: After 6 months, (compared with baseline) there were reductions in weight (107 ± 21Kg versus 112 ± 21, p<0.001, 4% body weight reduction), and improvements in HbA1c (7.4 ± 1.7 versus 8.0 ± 1.6%, p<0.05) and HDL cholesterol. Intake of energy (1589 ± 384 versus 2225 ± 1109 kcal, p<0.01), carbohydrate (199 ± 74 versus 273 ± 194 g, p<0.05), protein (78 ± 23 versus 98 ± 36 g, p<0.05), fats (55 ± 18 versus 84 ± 39 g, p<0.01) and several micronutrients were reduced. However, relative macronutrient composition of the diet was unchanged. Improvement in blood glucose was strongly correlated with a reduction in carbohydrate intake (r = 0.76, p<0.001). Conclusions: In obese patients with type 2 diabetes, rimonabant in combination with dietary intervention led to reduced intake of energy and most macronutrients. Despite this, macronutrient composition of the diet was unaltered. These dietary changes (especially carbohydrate restriction) were associated with weight loss and favourable metabolic effects.


Related Articles

  • Fenugreek For Blood Sugar and Weight Loss Management. Mathern, Jocey // Total Health;Oct/Nov2003, Vol. 25 Issue 5, 'Special section' p13 

    Evaluates the health benefits of Fenugreek for blood sugar control and weight loss management. Mechanism of action of FenuLife, a fenugreek extract; Comparison of the therapeutic effect of psyllium husk powder concentration and fenugreek extract; Physiologic effects of fenugreek.

  • DRIVING PRODUCT INNOVATION to Meet Modern Lifestyles. Leighton, Peter // Nutraceuticals World;Jun2014, Vol. 17 Issue 5, p32 

    The article reports that the increased demand of consumers for taste and convenience is important in the development of functional foods and beverages in the U.S. It focuses on the increased awareness of antioxidants. It mentions that fiber is important in maintaining a digestive system that...

  • The Way to Eat. Katz, David L. // O, The Oprah Magazine;Sep2005, Vol. 6 Issue 9, p162 

    Offers advice on health and diet. Nutritional content of dark chocolate; Effects of flaxseed and grapeseed oils on cholesterol and blood sugar levels; Recommended weight loss exercises.

  • Is PGX the next miracle medication?  // Active Living;May2006, Vol. 15 Issue 3, p11 

    Provides information on PolyGlycopex, a blend of three natural fibres said to help people lose weight, stabilize blood sugar and lower cholesterol. Background of Vladimir Vuksan, who concocted the product; Side effects of the product; Amount of water that should be taken per PolyGlycopex capsule.

  • You Want Me to Eat When? Berman, Jae // IDEA Fitness Journal;Apr2010, Vol. 7 Issue 4, p61 

    The article discusses the importance of meal timing and frequency in losing weight. The author explains that eating small meals frequently is essential in maintaining healthy blood glucose, insulin and cholesterol levels. It is noted that skipping breakfast is counterproductive to weight loss...

  • Double-duty diet pill. Harrar, Sarí N. // Prevention;Jun2006, Vol. 58 Issue 6, p38 

    The article reports that clinical trials are showing that the drug Rimonabant may help improve heart health and decrease weight. People taking the drug for a year lost 14 pounds, 2.4 inches around the waist, cut triglycerides by 5% and raised HDL cholesterol by 12%. The drug works to interfere...

  • METFORMIN FOR WEIGHT LOSS.  // Life Extension;Sep2004, Vol. 10 Issue 9, p32 

    Points out that while metformin is used to treat diabetes, published research shows that it also helps non-diabetics to lose weight. Ability of metformin to reduce sugar release from liver to prevent blood glucose levels from rising too high, so that the body does not need to produce as much...

  • Weight control breakthrough? Investor's Business Daily // Investors Business Daily;12/16/2014, pA02 

    A new treatment for obesity and associated adult-onset diabetes essentially cured lab animals, Ind. Univ. researchers said. In preclinical trials, a peptide — a combination of 3 gastrointestinal hormones — lowered blood sugar levels and reduced body fat beyond all existing drugs,...

  • Stop Yo-Yo Dieting for Good. Eckelkamp, Stephanie // Prevention;Apr2013, Vol. 65 Issue 4, p12 

    The article discusses various health aspects related to weight loss programs and weight loss diets concerning bad cholesterol and blood sugar that a human body develops while regaining weight. Researcher Daniel Beavers talks about a research that reveals that postmenopausal women regained weight...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics